2017
DOI: 10.1371/journal.pone.0174041
|View full text |Cite
|
Sign up to set email alerts
|

Mechanisms of glycosylase induced genomic instability

Abstract: Human alkyladenine DNA glycosylase (AAG) initiates base excision repair (BER) to guard against mutations by excising alkylated and deaminated purines. Counterintuitively, increased expression of AAG has been implicated in increased rates of spontaneous mutation in microsatellite repeats. This microsatellite mutator phenotype is consistent with a model in which AAG excises bulged (unpaired) bases, altering repeat length. To directly test the role of base excision in AAG-induced mutagenesis, we conducted mutatio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
4
1
1

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 71 publications
0
8
0
Order By: Relevance
“…BER-initiating enzyme APNG might be involved in temozolomide resistance due to increase in repair of N3 and N7 adducts in clinical setting [61]. Increased expression of APNG has been linked to genomic instability due to increase in spontaneous mutations, especially frameshift ones [85,86]. Overall, these data suggest that acquired resistance to temozolomide might develop independently from the induction of MGMT expression and may include MMR inactivation and/or acquisition of a mutator phenotype (Fig.…”
Section: The Use Of Temozolomide As a "Priming" Therapy For Sensitizimentioning
confidence: 93%
“…BER-initiating enzyme APNG might be involved in temozolomide resistance due to increase in repair of N3 and N7 adducts in clinical setting [61]. Increased expression of APNG has been linked to genomic instability due to increase in spontaneous mutations, especially frameshift ones [85,86]. Overall, these data suggest that acquired resistance to temozolomide might develop independently from the induction of MGMT expression and may include MMR inactivation and/or acquisition of a mutator phenotype (Fig.…”
Section: The Use Of Temozolomide As a "Priming" Therapy For Sensitizimentioning
confidence: 93%
“…3a ). MPG has not yet been described as a cancer-susceptibility gene, but studies in yeast and mice have demonstrated variants in this gene and, specifically, in its substrate-binding pocket, can lead to a mutator phenotype 47 , 48 (Supplementary Table 6 ). We examined the functional impact of the observed A135T variant using in vitro assays ( Methods and Extended Data Figs.…”
Section: Paternal Defects In Dna-repair Genesmentioning
confidence: 99%
“…Protein concentration was determined by absorbance at 280 nm. Active concentration was determined by electrophoretic mobility shift assay with 5'FAM-labeled pyrolidine-DNA (Supplemental Figure 8) 46 . Glycosylase assays were performed with 50 mM NaMOPS, pH 7.3, 172 mM potassium acetate, 1 mM DTT, 1 mM EDTA, 0.1 mg/mL BSA at 37 o C. For single turnover glycosylase activity, a 5'-FAM-labeled duplex was annealed by heating to 95 o C and slowly cooling to 4 o C (see Supplemental Figure 9).…”
Section: Kinetic Characterization Of Mpgmentioning
confidence: 99%
“…In the context of the protein, the variant amino-acid forms part of the substrate binding pocket and likely affects substrate specificity (Figure 3a). MPG has not yet been described as a cancer susceptibility gene, but studies in yeast and mice have demonstrated variants in this gene, and specifically the substrate binding pocket, can lead to a mutator phenotype 47,48 . We explored the functional impact of the observed A135T variant using in vitro assays (Methods, Supplemental Figures 8, 9).…”
Section: Identifying Germline Hypermutated Individuals In Rare Disease Cohortsmentioning
confidence: 99%
See 1 more Smart Citation